Immunoregulatory aberrations in systemic lupus erythematosus.
作者信息
Fauci A S, Steinberg A D, Haynes B F, Whalen G
出版信息
J Immunol. 1978 Oct;121(4):1473-9.
PMID:359708
Abstract
摘要
相似文献
1
Immunoregulatory aberrations in systemic lupus erythematosus.
J Immunol. 1978 Oct;121(4):1473-9.
2
Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.
J Clin Lab Immunol. 1982 Jun;8(2):83-90.
3
Heterogeneity of human suppressor cells induced by concanavalin A as determined in simultaneous assays of immune function.
J Immunol. 1980 Mar;124(3):1403-10.
4
Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus.
J Immunol. 1982 Jan;128(1):486-91.
5
Antibodies to activated T cells and their soluble products in systemic lupus erythematosus.
Arthritis Rheum. 1982 Jul;25(7):814-9. doi: 10.1002/art.1780250720.
6
Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
J Clin Lab Immunol. 1980 Sep;4(2):69-75.
7
Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
J Clin Invest. 1980 Feb;65(2):519-28. doi: 10.1172/JCI109696.
8
[Response of peripheral blood lymphocytes to antigenically nonspecific mitogens in systemic erythematosus].
Cas Lek Cesk. 1989 Jun 16;128(25):781-3.
9
Familial abnormalities of suppressor-cell function in systemic lupus erythematosus.
N Engl J Med. 1979 Oct 11;301(15):803-9. doi: 10.1056/NEJM197910113011502.
10
Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
Clin Exp Immunol. 1980 Oct;42(1):27-32.
引用本文的文献
1
Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.
Front Immunol. 2019 Mar 29;10:640. doi: 10.3389/fimmu.2019.00640. eCollection 2019.
2
Systemic lupus erythematosus.
Indian J Pediatr. 1996 Jul-Aug;63(4):485-500. doi: 10.1007/BF02905723.
3
Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.
J Clin Immunol. 1993 Jan;13(1):58-67. doi: 10.1007/BF00920636.
4
Mechanisms of autoimmunity in type I diabetes.
J Clin Immunol. 1993 Jan;13(1):1-7. doi: 10.1007/BF00920630.
5
Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.
Clin Rheumatol. 1993 Jun;12(2):204-9. doi: 10.1007/BF02231527.
6
Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.
J Clin Invest. 1994 Jul;94(1):422-30. doi: 10.1172/JCI117340.
7
Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus.
Clin Exp Immunol. 1994 Apr;96(1):15-9. doi: 10.1111/j.1365-2249.1994.tb06222.x.
8
Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis).
Clin Exp Immunol. 1982 Jul;49(1):59-66.
9
Autoimmune diseases: immunopathology and etiopathogenesis.
Am J Pathol. 1982 Sep;108(3):319-65.
10
Diseases associated with immunosuppression.
Environ Health Perspect. 1982 Feb;43:9-19. doi: 10.1289/ehp.82439.
Zotero 插件